Knight Therapeutics Inc. is a Canadian public specialty pharmaceutical company based in Montreal, Quebec that focuses on acquiring or in-licensing innovative...
5 KB (508 words) - 21:24, 12 September 2024
itself from issuing voting recommendations in a proxy contest at Knight Therapeutics, a Canadian company. In advance of the May 7th, 2019 vote, Glass...
8 KB (664 words) - 04:53, 4 June 2024
KEY Killam Properties Inc. KMP Kinaxis Inc. KXS Kinross Gold Corporation K Kirkland Lake Gold Inc. KL Knight Therapeutics Inc. GUD KP Tissue Inc. KPT...
1 KB (15 words) - 14:02, 3 July 2021
Antibe Therapeutics Robert Hoffman, former CFO, Heron Therapeutics; Director, public biotechnology companies Amal Khouri, VP Business Development, Knight Therapeutics...
13 KB (1,108 words) - 14:41, 16 June 2024
distribution partner in the MENA region is Hikma Pharmaceuticals LLC; Knight Therapeutics Inc. commercialises the antifungal Cresemba in South America. "David...
16 KB (1,506 words) - 18:03, 19 August 2024
itself from issuing voting recommendations in a proxy contest at Knight Therapeutics, a Canadian company. In advance of the May 7th, 2019 vote, Glass...
11 KB (1,320 words) - 14:33, 30 December 2024
Medison Pharma, rights in Canada to Knight Therapeutics, rights in South East Asian to Specialised Therapeutics and rights in Latin America to Pint Pharma...
9 KB (798 words) - 07:15, 29 February 2024
PRV to Sanofi for around $245 million, and later the same year, United Therapeutics Corp. sold a PRV for a drug for a rare pediatric disease to AbbVie Inc...
33 KB (3,432 words) - 02:00, 20 March 2024
shareholder and is on the boards of directors of Pulse Biosciences and Summit Therapeutics, where he is also CEO. Robert Duggan (Bob) was born in Oakland, California...
25 KB (2,387 words) - 06:54, 17 November 2024
Jonathan Ross Goodman (JD/LLB, MBA 1994) Founder, Executive Chairman Knight Therapeutics and founder of Paladin Labs Inc. Shaul Gordon (BCL/JD 2019, LLM 2021)...
95 KB (10,070 words) - 20:35, 29 December 2024
Knight Therapeutics Herb Gray – Canadian lawyer, prominent federal politician Jonathan Ross Goodman – founder, executive chairman Knight Therapeutics...
45 KB (4,411 words) - 21:58, 20 November 2024
low tax rates. "Exclusive: Endo considers sale of Paladin Labs to Knight Therapeutics - sources". Reuters. 4 November 2016. "Sumitomo agrees takeover of...
260 KB (26,809 words) - 08:42, 12 December 2024
Andrew Witty (category Knights Bachelor)
highlighting widespread anger at systemic issues in U.S. health care". G1 Therapeutics, non-executive director (since 2017) Synthego, member of the advisory...
20 KB (1,748 words) - 19:59, 26 December 2024
Hill+Knowlton Strategies Indegene Indivior IQVIA Janssen Johnson & Johnson Knight Therapeutics Kyowa Kirin Leo Pharma Lundbeck Lupin Pharmaceutical McCann McKesson...
10 KB (798 words) - 17:17, 19 February 2024
Endoceutics Gilead Sciences GlaxoSmithKline Horizon Therapeutics Incyte Ipsen Janssen JN Nova Knight Therapeutics Leo Pharma Lundbeck Medicago Merck Nordic Pharma...
12 KB (919 words) - 18:27, 19 February 2024
Reuters, via the New York Times. 12 March 2009. Gilead, a White Knight, to Buy CV Therapeutics Menarini press release. 18 June 2013 Memarii Group announces...
18 KB (1,549 words) - 23:35, 20 December 2024
"Diuretics: a review and update". Journal of Cardiovascular Pharmacology and Therapeutics. 19 (1): 5–13. doi:10.1177/1074248413497257. PMID 24243991. S2CID 21204143...
36 KB (3,607 words) - 01:52, 25 December 2024
Pharmaceuticals and its RNAi therapeutics, for $3.3 billion ($38.25 per share). In September 2022, Novo agreed to acquire Forma Therapeutics for $1.1 billion with...
43 KB (4,113 words) - 17:21, 2 January 2025
Therapeutics (Acq 2019) KaNDy Therapeutics Ltd (Acq 2020) Asklepios BioPharmaceutical (Acq 2020) Noria Therapeutics Inc. (Acq 2021) PSMA Therapeutics...
121 KB (11,533 words) - 18:59, 26 December 2024
Niels Ryberg Finsen (category Danish knights)
physiology to date. In 1904, Finsen was awarded the Cameron Prize for Therapeutics of the University of Edinburgh. Finsen married Ingeborg Balslev (1868–1963)...
10 KB (1,133 words) - 00:48, 10 December 2024
bid for the assets of BIND Therapeutics, which was in bankruptcy. The same month, the company acquired Bamboo Therapeutics for $645 million, expanding...
168 KB (14,766 words) - 16:58, 1 January 2025
they were engaged in the production of human (as opposed to veterinary) therapeutics. Included here are companies engaged not only in pharmaceutical development...
34 KB (2,178 words) - 05:15, 7 December 2024
2024 New Year Honours (section Knight Bachelor)
appointments, then by the honour and by the honour's grade (i.e. Knight/Dame Grand Cross, Knight/Dame Commander, etc.), and then by divisions (i.e. Civil, Diplomatic...
200 KB (26,471 words) - 13:53, 9 December 2024
George W. L. Bickley (category Knights of the Golden Circle)
Ohio, after being offered to serve as "Professor of Materia Medica, Therapeutics, and Medical Botany" at the Eclectic Medical Institute, an institution...
14 KB (1,346 words) - 06:08, 1 March 2024
Pharmacology and Experimental Therapeutics. 307 (3). Rockville, Maryland: American Society for Pharmacology and Experimental Therapeutics: 1179–1187. doi:10.1124/jpet...
35 KB (3,925 words) - 09:38, 30 December 2024
December 2014). "Treatment of adult-onset Still's disease: a review". Therapeutics and Clinical Risk Management. 11: 33–43. doi:10.2147/TCRM.S64951. PMC 4278737...
17 KB (1,757 words) - 13:36, 20 December 2024
sector, which includes investments in Unity Biotechnology, GRAIL, Juno Therapeutics, and Zocdoc. In January 2018, an announcement was made concerning Bezos's...
210 KB (17,275 words) - 23:38, 2 January 2025
based ever since. The company began to develop small molecule antiviral therapeutics in 1991, when the company in-licensed a group of nucleotide compounds...
79 KB (7,678 words) - 01:10, 11 December 2024
hypoxic stress, led McKnight to screen for and identify small-molecule inhibitors of HIF2alpha and then to found Peloton Therapeutics, a biotechnology company...
25 KB (2,872 words) - 02:15, 21 November 2024
1-year population-based prospective study". Alimentary Pharmacology & Therapeutics. 44 (6). Wiley: 592–600. doi:10.1111/apt.13738. ISSN 0269-2813. PMID 27444264...
65 KB (6,454 words) - 08:35, 3 December 2024